Coya taps familiar friend Dr. Reddy’s to commercialize ALS med

Neurodegenerative biotech Coya Therapeutics has handed over key commercialization rights to an amyotrophic lateral sclerosis prospect to existing partner Dr. Reddy’s, and it's also fundraising off the deal.